IL95082A - תהליך לזיכוך אנקסינים - Google Patents

תהליך לזיכוך אנקסינים

Info

Publication number
IL95082A
IL95082A IL9508290A IL9508290A IL95082A IL 95082 A IL95082 A IL 95082A IL 9508290 A IL9508290 A IL 9508290A IL 9508290 A IL9508290 A IL 9508290A IL 95082 A IL95082 A IL 95082A
Authority
IL
Israel
Prior art keywords
process according
vac
annexines
buffer
added
Prior art date
Application number
IL9508290A
Other languages
English (en)
Other versions
IL95082A0 (en
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL95082A0 publication Critical patent/IL95082A0/xx
Publication of IL95082A publication Critical patent/IL95082A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Detergent Compositions (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Amplifiers (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL9508290A 1989-07-15 1990-07-13 תהליך לזיכוך אנקסינים IL95082A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3923501 1989-07-15

Publications (2)

Publication Number Publication Date
IL95082A0 IL95082A0 (en) 1991-06-10
IL95082A true IL95082A (he) 1995-03-30

Family

ID=6385155

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9508290A IL95082A (he) 1989-07-15 1990-07-13 תהליך לזיכוך אנקסינים

Country Status (18)

Country Link
US (1) US5258497A (he)
EP (1) EP0409053B1 (he)
JP (1) JPH03175992A (he)
KR (1) KR0159275B1 (he)
AT (1) ATE95189T1 (he)
AU (1) AU628604B2 (he)
CA (1) CA2021147A1 (he)
DD (1) DD297977A5 (he)
DE (2) DE4021979A1 (he)
DK (1) DK0409053T3 (he)
ES (1) ES2045669T3 (he)
FI (1) FI95136C (he)
IE (1) IE65195B1 (he)
IL (1) IL95082A (he)
NO (1) NO177787C (he)
NZ (1) NZ234492A (he)
PT (1) PT94674B (he)
ZA (1) ZA905490B (he)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0409052B1 (de) * 1989-07-15 1993-05-12 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Antikoagulanz enthaltendes Mittel
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
DE9110757U1 (de) * 1991-08-30 1992-02-13 Klein, Rainer, 5840 Schwerte Integriert-optischer Stoffsensor
WO1993006230A1 (en) * 1991-09-23 1993-04-01 The General Hospital Corporation Annexin xi
DE69530375T2 (de) * 1994-01-24 2004-02-05 Neorx Corp., Seattle Radioaktiv-markierte annexine
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
CA2206274C (en) * 1994-12-07 2009-06-30 Neorx Corporation Radiolabeled annexin-galactose cluster conjugates
US6204035B1 (en) * 1996-04-02 2001-03-20 The Blood Center Research Foundation Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids
US6172210B1 (en) 1996-04-02 2001-01-09 Blood Center Research Foundation DNA encoding phospholipid scramblase
EP1306383B1 (en) * 2000-07-21 2009-03-25 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Method of purifying a calcium ion-binding protein
US7635680B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
DE60219611T2 (de) * 2001-02-21 2007-12-27 Alavita Pharmaceuticals, Inc., Mountain View Modifizierte annexin-proteine und verhinderung und behandlung von thrombose
US7645739B2 (en) * 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
US7635676B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US20090291086A1 (en) * 2001-02-21 2009-11-26 Alavita Pharmaceuticals, Inc. Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia
US20050222030A1 (en) * 2001-02-21 2005-10-06 Anthony Allison Modified annexin proteins and methods for preventing thrombosis
DE10162434A1 (de) * 2001-12-18 2003-09-25 November Ag Molekulare Medizin Expressionsvektor und Verfahren zur Herstellung eines Expressionsvektors
WO2003103700A1 (en) * 2002-06-07 2003-12-18 U.S. Department Of Veterans Affairs Method and composition for inhibing or slowing blood coagulation
US7771956B2 (en) * 2003-06-30 2010-08-10 Brigham & Women's Hospital, Inc. Method for detecting the presence of a phospholipid
KR102597544B1 (ko) * 2021-04-02 2023-11-03 주식회사 디에스시동탄 시트용 서포트 구동부 및 이를 포함하는 서포트 어셈블리

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315000A1 (de) * 1983-04-26 1984-10-31 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)4(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
DE3533516A1 (de) * 1984-09-21 1986-04-03 Boehringer Ingelheim KG, 6507 Ingelheim Blutgerinnungshemmende proteine, verfahren zur herstellung sowie deren verwendung
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
US4937324A (en) * 1987-02-06 1990-06-26 Zymogenetics, Inc. Chromatographic purification of human proteins having anticoagulant and anti-inflammatory activity

Also Published As

Publication number Publication date
IE65195B1 (en) 1995-10-04
KR0159275B1 (ko) 1998-11-16
EP0409053B1 (de) 1993-09-29
DE4021979A1 (de) 1991-01-31
AU5901590A (en) 1991-01-17
NO903149D0 (no) 1990-07-13
NO177787C (no) 1995-11-22
PT94674B (pt) 1997-03-31
DD297977A5 (de) 1992-01-30
FI95136B (fi) 1995-09-15
ATE95189T1 (de) 1993-10-15
NO177787B (no) 1995-08-14
NO903149L (no) 1991-01-16
DK0409053T3 (da) 1993-11-08
EP0409053A1 (de) 1991-01-23
ZA905490B (en) 1992-03-25
FI95136C (fi) 1995-12-27
JPH03175992A (ja) 1991-07-31
DE59002895D1 (de) 1993-11-04
FI903508A0 (fi) 1990-07-11
NZ234492A (en) 1991-10-25
KR910002893A (ko) 1991-02-26
US5258497A (en) 1993-11-02
CA2021147A1 (en) 1991-01-16
IL95082A0 (en) 1991-06-10
IE902563A1 (en) 1991-02-27
ES2045669T3 (es) 1994-01-16
PT94674A (pt) 1991-04-18
AU628604B2 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
US5258497A (en) Process for purifying annexines
NO167627B (no) Fremgangsmaate for rensing av faktor viii:c.
JP2001086984A (ja) アフィニティークロマトグラフィーによって血液凝固第ｖｉｉ因子を活性化するプロテアーゼ、そのプロ酵素または両タンパク質の混合物を純粋形態で調製する方法
EP0263608A2 (en) Protein having anticoagulant and antimetastatic properties
JP2003504082A (ja) エカリンポリペプチド、エカリンをコードするポリヌクレオチド、及びその利用のための方法
JPH03197495A (ja) 毒ヘビの毒ポリペプチド及び変異体
US6068838A (en) Purified multimerase
CA2252986C (en) Process for preparing functional recombinant tissue factor
US4137127A (en) Process for the preparation of thrombin-like enzymes from snake venoms
WO1995003332A1 (en) Activated human factor viii and method of preparation
Iwasaki et al. Purification and Characterization of a Coagulant Enzyme, Okinaxobin I, from the Venom of Trimeresums okinavensis (Himehabu Snake) Which Releases Fibrinopeptide B
JP3819935B2 (ja) トロンビンの調製
US6010844A (en) Methods of preparing and recovering proteins
Malhotra Purification and characterization of dicoumarol-induced prothrombins. III. Alumina pH 4.6 atypical (2-Gla)+ variant
EP0395375B1 (en) Novel DNA sequences which encode ancrod-like polypeptides and compositions comprising the expression products thereof
AU4311893A (en) Purification of kringle containing proteins, and especially t-pa
Váradi et al. Purification and properties of human factor IXa
AU645804B2 (en) Treatment of thrombotic events
US2871165A (en) Process for preparing pankrin
Amin et al. Direct Cloning, Expression and Purification of Human Activated Thrombin in Prokaryotic System and CD Analysis Report of Produced Thrombin: Molecular Characterization of Recombinant Thrombin
WO1999060126A2 (en) Protein z-dependent protease inhibitor
FI100406B (fi) Menetelmä vampyyrilepakon syljen plasminogeeniaktivaattoreiden valmist amiseksi
JPS6336781A (ja) 高純度組織性プラスミノ−ゲン活性化因子の製法
JPS63146900A (ja) 抗凝血性及び抗転移性特性を有するタンパク質
Sun et al. Effects of temperature, pH, and inhibitors on the procoagulant characterization of FIa, a factor X activator from the venom of Daboia russellii siamensis (Myanmar)

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed